Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 1.00 |
| ▸ | HPGD | P15428 | 4/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 1.00 |
| ▸ | NPC1 | O15118 | 3/20 | 1.00 |
| ▸ | RAB9A | P51151 | 3/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 2/20 | 1.00 |
| ▸ | PKM | P14618 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | ABCC4 | O15439 | 1/20 | 1.00 |
| ▸ | HPGDS | O60760 | 1/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tranilast SCHEMBL8696829 | 1.00 | MEN1 (1.00) | MEN1KMT2AALDH1A1HPGDSMN1; SMN2 | |
| Tranilast SCHEMBL30053800 | 1.00 | MEN1 (1.00) | MEN1KMT2AALDH1A1HPGDSMN1; SMN2 | |
| Tranilast SCHEMBL10978582 | 1.00 | MEN1 (1.00) | MEN1KMT2AALDH1A1HPGDSMN1; SMN2 | |
| Tranilast SCHEMBL29366319 | 1.00 | MEN1 (1.00) | MEN1KMT2AALDH1A1HPGDSMN1; SMN2 | |
| Tranilast SCHEMBL29556872 | 1.00 | MEN1 (1.00) | MEN1KMT2AALDH1A1HPGDSMN1; SMN2 | |
| Tranilast SCHEMBL29876 | 1.00 | MEN1 (1.00) | MEN1KMT2AALDH1A1HPGDSMN1; SMN2 | |
| Tranilast SCHEMBL30352530 | 1.00 | MEN1 (1.00) | MEN1KMT2AALDH1A1HPGDSMN1; SMN2 | |
| Tranilast SCHEMBL1829087 | 0.99 | MEN1 (0.98) | MEN1KMT2AALDH1A1HPGDSMN1; SMN2 | |
| Tranilast SCHEMBL20770072 | 0.99 | MEN1 (0.98) | MEN1KMT2AALDH1A1HPGDSMN1; SMN2 | |
| Tranilast SCHEMBL10868728 | 0.99 | MEN1 (0.98) | MEN1KMT2AALDH1A1HPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 13778 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731204-A2 | SELECTIVE RBP4 ANTAGONIST AND C20-D3-RETINOL FOR TREATING MACULAR DEGENERATION, NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), AND GOUTY ARTHRITIS (GOUT) | The Trustees Of Columbia University In The City Of New York (US) | 2026-04-29 | — | — | EP | claimed |
| US-20260091162-A1 | SPRAYABLE POLYMERIC SCAFFOLD LOADED WITH INFLAMMASOME-INHIBITING LIPID NANORODS FOR ANTI-INFLAMMATION THERAPY | KULKARNI ASHISH (US) | 2026-04-02 | — | — | US | claimed |
| EP-4704971-A1 | GAMMA STIMULATION AND NEUROMODULATOR COMBINATION THERAPY | Cognito Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| US-12569451-B2 | Bio-inspired tissue-adhesive hydrogel patch and uses thereof | Cellartgen Inc. (KR) | 2026-03-10 | — | — | US | claimed |
| US-20260027230-A1 | DRUG DELIVERY SYSTEM, TREATMENT KIT, AND METHOD FOR INHIBITING PROLIFERATION OR METASTASIS OF CANCER CELL | CHINA MEDICAL UNIVERSITY (TW) | 2026-01-29 | — | — | US | claimed |
| EP-4674894-A2 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | Hemoteq AG (DE) | 2026-01-07 | — | — | EP | claimed |
| US-20260000663-A1 | RBP4 ANTAGONISTS FOR TREATMENT AND PREVENTION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND GOUT | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2026-01-01 | — | — | US | claimed |
| US-20250381202-A1 | PRODRUG KIT FOR MULTI-PRONGED CHEMOTHERAPY | ZOUNEK ALEX (DE) | 2025-12-18 | — | — | US | claimed |
| EP-4663688-A2 | CROSSLINKERS | Hemoteq AG (DE) | 2025-12-17 | — | — | EP | claimed |
| US-20250375534-A1 | COMPLEXES FOR DELIVERY OF NUCLEIC ACIDS | BioNTech SE (DE) | 2025-12-11 | — | — | US | claimed |
| EP-0588518-A1 | Use of 2-(3,4-dimethoxycinnamoyl)-aminobenzoic acid for the manufacture of a medicament for the treatment of restenosis | Kissei Pharmaceutical Co., Ltd. (JP) | 1994-03-23 | — | — | EP | claimed |
| US-5288503-A | WATER-PERMEABLE DIFFUSION BARRIER OF POLYVINYL ALCOHOL | SRCHEM INCORPORATED (US) | 1994-02-22 | — | — | US | claimed |
| US-5260066-A | Cryogel bandage containing therapeutic agent | SRCHEM INCORPORATED (US) | 1993-11-09 | — | — | US | claimed |
| US-5087455-A | HOLLOW GRANULAR MEDICINE AND ITS PREPARATION | SHOWA YAKUHIN KAKO CO. LTD. (JP) | 1992-02-11 | — | — | US | claimed |
| US-5051406-A | Protein as a binder for drugs | NIPPON HYPOX LABORATORIES INCORPORATED (JP) | 1991-09-24 | — | — | US | claimed |
| EP-0391002-A2 | Pharmaceutical compositions containing N-(3,4-dimethoxycinnamoyl) anthranilic acid | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 1990-10-10 | — | — | EP | claimed |
| EP-0167825-A2 | Lipid nano pellets as drug carriers for oral administration | Dr. Rentschler Arzneimittel GmbH & Co. (DE) | 1986-01-15 | — | — | EP | claimed |
| EP-0074725-B1 | A METHOD FOR THE PRODUCTION OF NUCLEAR SUBSTITUTED CINNAMOYLANTHRANILIC ACID DERIVATIVES AND INTERMEDIATES THEREOF | Kissei Pharmaceutical Co. Ltd. (JP) | 1985-12-27 | — | — | EP | claimed |
| US-4486597-A | Method for the production of nuclear substituted cinnamoylanthranilic acid derivatives | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 1984-12-04 | — | — | US | claimed |
| EP-0074725-A1 | A method for the production of nuclear substituted cinnamoylanthranilic acid derivatives and intermediates thereof | Kissei Pharmaceutical Co. Ltd. (JP) | 1983-03-23 | — | — | EP | claimed |